SCHEMBL903973

SCHEMBL903973

CCc1cnc(N2CC3C(CO)C3C2)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 9/20 0.36
HDAC4 P56524 9/20 0.36
HDAC1 Q13547 9/20 0.36
HDAC7 Q8WUI4 9/20 0.36
HDAC2 Q92769 9/20 0.36
HDAC10 Q969S8 9/20 0.36
HDAC11 Q96DB2 9/20 0.36
HDAC8 Q9BY41 9/20 0.36
HDAC6 Q9UBN7 9/20 0.36
HDAC9 Q9UKV0 9/20 0.36
HDAC5 Q9UQL6 9/20 0.36
OGA O60502 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
ACACB O00763 3/20 0.34
GPR119 Q8TDV5 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
PDE8B O95263 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10067574 0.84 OGA (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL903913 0.80 OGA (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10067598 0.80 HDAC3 (0.37) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10067779 0.80 HDAC3 (0.37) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL12525218 0.80 OGA (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL904189 0.79 ACACB (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8203125 0.79 ACACB (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL26791620 0.77 OGA (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL26812601 0.77 OGA (0.42) OGANPC1RAB9AACACBGPR119
SCHEMBL20064433 0.76 HRH3 (0.41) OGANPC1RAB9AACACBGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041158-A1 TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-04-05 WO disclosed